Compounds > almagate
Page last updated: 2024-08-25

almagate and Bacterial Eye Infections

almagate has been researched along with Bacterial Eye Infections in 9 studies

Research

Studies (9)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's9 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Albini, TA; Berrocal, AM; Davis, JL; Dubovy, SR; Flynn, HW; Fortun, JA; Gregori, NZ; Kovach, JL; Moshfeghi, AA; Rosenfeld, PJ; Schwartz, SG; Smiddy, WE; Vaziri, K1
Becker, M; Brynskov, T; Freiberg, FJ; Michels, S; Munk, MR; Sørensen, TL; Wirth, MA; Wolf, S1
Anderson, NG; Inman, ZD1
McCannel, CA1
Inoue, M; Kadonosono, K; Kinoshita, S; Kobayakawa, S; Komori, H; Matsushima, H; Senoo, T; Sotozono, C; Suda, Y; Tanaka, K; Tochikubo, T1
Albini, TA; Berrocal, AM; Davis, JL; Dubovy, SR; Flynn, HW; Kovach, JL; Lalwani, GA; Lee, WH; Moshfeghi, AA; Murray, TG; Puliafito, CA; Rosenfeld, PJ; Schwartz, SG; Smiddy, WE1
Brown, DM; Chen, E; Cox, J; Lin, MY1
Fujita, K; Hattori, T; Mori, R; Nakashizuka, H; Shimada, H; Yuzawa, M1
Chen, TC; Englander, M; Kim, IK; Miller, JW; Paschalis, EI1

Reviews

1 review(s) available for almagate and Bacterial Eye Infections

ArticleYear
Meta-analysis of endophthalmitis after intravitreal injection of anti-vascular endothelial growth factor agents: causative organisms and possible prevention strategies.
    Retina (Philadelphia, Pa.), 2011, Volume: 31, Issue:4

    Topics: Angiogenesis Inhibitors; Antibodies, Monoclonal, Humanized; Aptamers, Nucleotide; Bacteria; Endophthalmitis; Eye Infections, Bacterial; Humans; Incidence; Intravitreal Injections; Ranibizumab; Vascular Endothelial Growth Factor A

2011

Other Studies

8 other study(ies) available for almagate and Bacterial Eye Infections

ArticleYear
Current Infectious Endophthalmitis Rates After Intravitreal Injections of Anti-Vascular Endothelial Growth Factor Agents and Outcomes of Treatment.
    Ophthalmic surgery, lasers & imaging retina, 2015, Volume: 46, Issue:6

    Topics: Angiogenesis Inhibitors; Anti-Bacterial Agents; Aptamers, Nucleotide; Bevacizumab; Endophthalmitis; Eye Infections, Bacterial; Florida; Humans; Incidence; Intravitreal Injections; Ranibizumab; Receptors, Vascular Endothelial Growth Factor; Recombinant Fusion Proteins; Retinal Diseases; Treatment Outcome; Vascular Endothelial Growth Factor A; Visual Acuity

2015
LOW ENDOPHTHALMITIS RATES AFTER INTRAVITREAL ANTI-VASCULAR ENDOTHELIAL GROWTH FACTOR INJECTIONS IN AN OPERATION ROOM: A Retrospective Multicenter Study.
    Retina (Philadelphia, Pa.), 2017, Volume: 37, Issue:12

    Topics: Angiogenesis Inhibitors; Aptamers, Nucleotide; Bevacizumab; Denmark; Endophthalmitis; Equipment Contamination; Eye Infections, Bacterial; Follow-Up Studies; Humans; Incidence; Intravitreal Injections; Operating Rooms; Ranibizumab; Receptors, Vascular Endothelial Growth Factor; Recombinant Fusion Proteins; Retrospective Studies; Risk Factors; Switzerland; Time Factors; Vascular Endothelial Growth Factor A; Wet Macular Degeneration

2017
Incidence of endophthalmitis after intravitreal injection of antivascular endothelial growth factor medications using topical lidocaine gel anesthesia.
    Retina (Philadelphia, Pa.), 2011, Volume: 31, Issue:4

    Topics: Anesthesia, Local; Anesthetics, Local; Angiogenesis Inhibitors; Antibodies, Monoclonal, Humanized; Aptamers, Nucleotide; Bevacizumab; Endophthalmitis; Eye Infections, Bacterial; Humans; Incidence; Intravitreal Injections; Lidocaine; Ranibizumab; Retrospective Studies; Time Factors; Vascular Endothelial Growth Factor A; Visual Acuity

2011
Evaluation of the incidence of endophthalmitis after intravitreal injection of anti-vascular endothelial growth factor.
    Ophthalmologica. Journal international d'ophtalmologie. International journal of ophthalmology. Zeitschrift fur Augenheilkunde, 2011, Volume: 226, Issue:3

    Topics: Aged, 80 and over; Angiogenesis Inhibitors; Antibodies, Monoclonal, Humanized; Aptamers, Nucleotide; Aqueous Humor; Bevacizumab; Endophthalmitis; Enterococcus faecalis; Eye Infections, Bacterial; Gram-Positive Bacterial Infections; Humans; Incidence; Intravitreal Injections; Japan; Middle Aged; Postoperative Complications; Ranibizumab; Retrospective Studies; Streptococcal Infections; Streptococcus oralis; Vascular Endothelial Growth Factor A; Vitreous Body

2011
Endophthalmitis after intravitreal vascular [corrected] endothelial growth factor antagonists: a six-year experience at a university referral center.
    Retina (Philadelphia, Pa.), 2011, Volume: 31, Issue:4

    Topics: Academic Medical Centers; Aged; Aged, 80 and over; Angiogenesis Inhibitors; Antibodies, Monoclonal, Humanized; Aptamers, Nucleotide; Aqueous Humor; Bacteria; Bevacizumab; Endophthalmitis; Eye Infections, Bacterial; Female; Humans; Intravitreal Injections; Macular Degeneration; Male; Middle Aged; Ranibizumab; Referral and Consultation; Retrospective Studies; Vascular Endothelial Growth Factor A; Visual Acuity; Vitreous Body

2011
Endophthalmitis after intravitreal injection: the importance of viridans streptococci.
    Retina (Philadelphia, Pa.), 2011, Volume: 31, Issue:8

    Topics: Adult; Aged; Aged, 80 and over; Angiogenesis Inhibitors; Antibodies, Monoclonal, Humanized; Aptamers, Nucleotide; Bevacizumab; Endophthalmitis; Eye Infections, Bacterial; Female; Glucocorticoids; Humans; Incidence; Intravitreal Injections; Male; Middle Aged; Ranibizumab; Retinal Diseases; Retrospective Studies; Risk Factors; Streptococcal Infections; Triamcinolone Acetonide; Viridans Streptococci; Visual Acuity; Vitreous Body

2011
Minimizing the endophthalmitis rate following intravitreal injections using 0.25% povidone-iodine irrigation and surgical mask.
    Graefe's archive for clinical and experimental ophthalmology = Albrecht von Graefes Archiv fur klinische und experimentelle Ophthalmologie, 2013, Volume: 251, Issue:8

    Topics: Angiogenesis Inhibitors; Anti-Bacterial Agents; Anti-Infective Agents; Antibodies, Monoclonal, Humanized; Aptamers, Nucleotide; Bevacizumab; Conjunctiva; Endophthalmitis; Eye Infections, Bacterial; Humans; Intravitreal Injections; Levofloxacin; Masks; Povidone-Iodine; Ranibizumab; Retrospective Studies; Therapeutic Irrigation; Vascular Endothelial Growth Factor A

2013
Intravitreal injections at the Massachusetts Eye and Ear Infirmary: analysis of treatment indications and postinjection endophthalmitis rates.
    The British journal of ophthalmology, 2013, Volume: 97, Issue:4

    Topics: Academic Medical Centers; Acute Disease; Aged; Angiogenesis Inhibitors; Anti-Bacterial Agents; Antibodies, Monoclonal, Humanized; Aptamers, Nucleotide; Bevacizumab; Endophthalmitis; Eye Infections, Bacterial; Female; Humans; Incidence; Intravitreal Injections; Male; Massachusetts; Postoperative Complications; Ranibizumab; Retinal Diseases; Retrospective Studies; Triamcinolone Acetonide; Vascular Endothelial Growth Factor A; Visual Acuity

2013